CoChat

Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome

Ahmed, M.I., Duleba, A.J., El Shahat, O., Ibrahim, M.E., Salem, A. · 2008 · Human Reproduction

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Endogenous opiates may affect various aspects of reproductive and metabolic function in patients with polycystic ovary syndrome (PCOS). This study evaluated long-term inhibition of the opioid system using naltrexone in clomiphene citrate (CC)-resistant women with PCOS. METHODS: A group of 30 infertile females with PCOS were evaluated; all subjects were obese, hyperandrogenic and hyperinsulinemic; 16 patients were amenorrhic and 14 were oligomenorrhic. All subjects received natrexone (50 mg p.o. daily) for 6 months. Patients who did not ovulate after 12 weeks of naltrexone monotherapy, also received CC (starting at 50 mg/day for 5 days and, for non-responders, increasing it up to 150 mg/day). RESULTS: Of the 30 women, 3 ovulated during naltrexone monotherapy and 19 of the remaining 27 ovulated during naltrexone + CC therapy. There were no conceptions during naltrexone monotherapy, but 9 of 27 women (33.3%) conceived during naltrexone + CC; there was one missed abortion at 9 weeks, one preterm delivery at 34 weeks and seven term live births. Naltrexone therapy was also followed by significant reductions in BMI, fasting serum insulin, luteinizing hormone (LH), LH/follicle-stimulating hormone ratio and testosterone. CONCLUSIONS: In this preliminary trial, naltrexone improved endocrine and metabolic function in women with CC-resistant PCOS. Furthermore, naltrexone restored CC sensitivity in the majority of subjects, resulting in a significant number of pregnancies.

Overview

Integrity signals

Registry

Crossref · 10.1093/humrep/den273

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Research works printed but not linked: 3

  1. Guido, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 1742, 10.1210/jc.83.5.1742 · doi:10.1210/jc.83.5.1742
  2. Malcolm, 1986, NIDA research monograph, 75, 371
  3. 1988, 1, 870

Cited by

See all 58

Metadata

Authors
Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A.
Affiliations
Benha University (EG)
Venue
Human Reproduction
Published
2008-07-29
Volume
23
Issue
11
Pages
2564-2569
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2156291382
Cited by
58
References
53
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 3 · 2016: 3 · 2014: 3 · 2013: 7 · 2012: 2
FWCI
5.79
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
naltrexone, polycystic ovary syndrome, clomiphene citrate resistance, opioid system, ovulation induction, infertility, hyperandrogenism, hyperinsulinemia, luteinizing hormone, testosterone, body mass index, pregnancy outcomes
MeSH terms
Adolescent, Adult, Analgesics, Opioid, Clomiphene, Drug Resistance, Estrogen Antagonists, Female, Humans, Infertility, Female, Luteinizing Hormone, Naltrexone, Narcotic Antagonists, Polycystic Ovary Syndrome, Pregnancy, Body Mass Index, Pregnancy Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1093/humrep/den273
The paper
Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A. (2008). Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. Human Reproduction. https://doi.org/10.1093/humrep/den273

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.